About this trial
This clinical trial is studying how well new imaging tests can find tumors in people with brain metastases. The main goal is to see if a type of scan called PET, along with MRI, can detect cancerous tissue better than other imaging methods. Participants will have a PET/MRI scan followed by another MRI scan, and the entire visit will take about 3 hours.
The trial's ID number is NCT06159335. It is a Phase 3 trial, which means the study is looking at how well the imaging works and how safe it is. This trial is not for a drug but involves a regulated imaging device. Around 30 participants are expected to join the study.
Who can join
Adults aged 18 and older can join this trial. It is open to both men and women. You need a diagnosis of brain metastasis and a recent MRI showing at least one tumor. Having received radiation therapy or certain treatments in the past 2 years is also necessary. If you can lie still for the scan and are not pregnant, you can be considered. The trial team will confirm eligibility before participation.
Conditions
Brain Metastasis, Radiation Therapy, Immunotherapy, Active
Age group
Adult, Older adult
The study team makes the final call on eligibility.
What happens in the study
Participants will receive a special PET radiotracer and undergo an MRI scan. Everyone in the trial will have the same treatment, which involves a single group of participants receiving the PET/MRI scan. There is no random group assignment in this study.
Where
This trial is running at 1 location in the United States. It is currently recruiting.
University of Wisconsin
Madison, Wisconsin